AARTI Industries Ltd (AARTIIND) Price & Analysis

Aarti Industries Limited, established in 1984 and headquartered in Mumbai, India, is a prominent manufacturer and supplier of both specialty chemicals and pharmaceutical products. The company's chemical division produces a wide array of compounds including dichlorobenzene, various nitro-chloro and nitro-benzene derivatives, nitro-toluenes, and sulfur, along with other organic and inorganic substances. These crucial materials serve as intermediates for a diverse range of sectors such as agrochemicals, pharmaceuticals, polymer and fuel additives, fast-moving consumer goods (FMCG), dyes, pigments, paints, printing inks, rubber chemicals, and resins. In the pharmaceutical sphere, Aarti Industries develops active pharmaceutical ingredients (APIs) utilized in medications for conditions like hypertension, asthma, cancer, thalassemia, pain relief, ophthalmic disorders, and central nervous system agents, as well as skincare and decongestant products. They also supply pharmaceutical intermediates and a selection of xanthine derivatives, prominently featuring caffeine anhydrous, theophylline, and related compounds. Beyond its manufacturing capabilities, Aarti Industries provides contract manufacturing and research services. The company maintains a significant global presence, exporting its products to approximately 60 countries across North America, Europe, China, Japan, and other international regions.